Novel motif:97
From FANTOM5_SSTAR
name: | motif97_TTCCCT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0023052 | signaling | 7.392064e-18 |
GO:0051716 | cellular response to stimulus | 1.612211e-17 |
GO:0007165 | signal transduction | 3.068920e-17 |
GO:0007154 | cell communication | 1.136325e-16 |
GO:0050896 | response to stimulus | 5.028105e-16 |
GO:0002376 | immune system process | 1.183045e-13 |
GO:0006955 | immune response | 2.753134e-10 |
GO:0009612 | response to mechanical stimulus | 7.985176e-10 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 1.271766e-9 |
GO:0010243 | response to organic nitrogen | 8.902804e-9 |
GO:0060346 | bone trabecula formation | 1.083353e-8 |
GO:0048705 | skeletal system morphogenesis | 1.267384e-8 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 2.164905e-8 |
GO:0000117 | regulation of transcription involved in G2/M-phase of mitotic cell cycle | 2.656343e-8 |
GO:0045619 | regulation of lymphocyte differentiation | 2.743222e-8 |
GO:0009617 | response to bacterium | 3.260517e-8 |
GO:0046320 | regulation of fatty acid oxidation | 4.929153e-8 |
GO:0070887 | cellular response to chemical stimulus | 5.637673e-8 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 5.705915e-8 |
GO:0061084 | negative regulation of protein refolding | 5.856705e-8 |
GO:0015695 | organic cation transport | 6.198288e-8 |
GO:0045580 | regulation of T cell differentiation | 6.307863e-8 |
GO:2000171 | negative regulation of dendrite development | 1.087680e-7 |
GO:0046321 | positive regulation of fatty acid oxidation | 1.128492e-7 |
GO:0051971 | positive regulation of transmission of nerve impulse | 1.165811e-7 |
GO:0060349 | bone morphogenesis | 1.839424e-7 |
GO:0010033 | response to organic substance | 1.902437e-7 |
GO:0048518 | positive regulation of biological process | 1.953029e-7 |
GO:0001957 | intramembranous ossification | 2.060936e-7 |
GO:0048706 | embryonic skeletal system development | 2.077447e-7 |
GO:0006952 | defense response | 2.156395e-7 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.231350e-7 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 2.282276e-7 |
GO:0061383 | trabecula morphogenesis | 2.427985e-7 |
GO:0016477 | cell migration | 3.239215e-7 |
GO:0051249 | regulation of lymphocyte activation | 3.905989e-7 |
GO:0048522 | positive regulation of cellular process | 4.072126e-7 |
GO:0030225 | macrophage differentiation | 4.393322e-7 |
GO:0050863 | regulation of T cell activation | 4.726845e-7 |
GO:0043149 | stress fiber assembly | 4.867630e-7 |
GO:0031646 | positive regulation of neurological system process | 5.170344e-7 |
GO:0043200 | response to amino acid stimulus | 5.892461e-7 |
GO:0031331 | positive regulation of cellular catabolic process | 6.015000e-7 |
GO:0050806 | positive regulation of synaptic transmission | 6.282940e-7 |
GO:0060343 | trabecula formation | 6.766303e-7 |
GO:0022612 | gland morphogenesis | 7.320730e-7 |
GO:0060348 | bone development | 7.486735e-7 |
GO:0051094 | positive regulation of developmental process | 7.994026e-7 |
GO:0001503 | ossification | 8.305520e-7 |
GO:0060350 | endochondral bone morphogenesis | 9.739134e-7 |
GO:0050870 | positive regulation of T cell activation | 1.000867e-6 |
GO:0046677 | response to antibiotic | 1.251118e-6 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 1.531067e-6 |
GO:0072283 | metanephric renal vesicle morphogenesis | 1.588853e-6 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 1.640175e-6 |
GO:0010628 | positive regulation of gene expression | 1.683210e-6 |
GO:0045621 | positive regulation of lymphocyte differentiation | 1.788249e-6 |
GO:0051251 | positive regulation of lymphocyte activation | 1.814074e-6 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 1.893928e-6 |
GO:0002009 | morphogenesis of an epithelium | 1.901356e-6 |
GO:0042307 | positive regulation of protein import into nucleus | 2.155242e-6 |
GO:0010647 | positive regulation of cell communication | 2.236241e-6 |
GO:0045597 | positive regulation of cell differentiation | 2.240343e-6 |
GO:0006182 | cGMP biosynthetic process | 2.257655e-6 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 2.621353e-6 |
GO:0001754 | eye photoreceptor cell differentiation | 2.763426e-6 |
GO:0009893 | positive regulation of metabolic process | 2.803179e-6 |
GO:0060740 | prostate gland epithelium morphogenesis | 2.867282e-6 |
GO:0033025 | regulation of mast cell apoptosis | 3.172592e-6 |
GO:0034764 | positive regulation of transmembrane transport | 3.373032e-6 |
GO:0023056 | positive regulation of signaling | 3.813556e-6 |
GO:0048732 | gland development | 3.945698e-6 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.981614e-6 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 4.057268e-6 |
GO:0032496 | response to lipopolysaccharide | 4.276377e-6 |
GO:0048870 | cell motility | 4.326053e-6 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 4.425801e-6 |
GO:2000612 | regulation of thyroid-stimulating hormone secretion | 4.541603e-6 |
GO:0060512 | prostate gland morphogenesis | 4.745316e-6 |
GO:0071363 | cellular response to growth factor stimulus | 4.751080e-6 |
GO:0045582 | positive regulation of T cell differentiation | 4.783093e-6 |
GO:0010604 | positive regulation of macromolecule metabolic process | 4.832012e-6 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 4.877091e-6 |
GO:0007166 | cell surface receptor linked signaling pathway | 4.893086e-6 |
GO:0070848 | response to growth factor stimulus | 5.181566e-6 |
GO:0006959 | humoral immune response | 5.371567e-6 |
GO:0014075 | response to amine stimulus | 5.451546e-6 |
GO:0014003 | oligodendrocyte development | 6.140381e-6 |
GO:0033273 | response to vitamin | 6.268589e-6 |
GO:0061077 | chaperone-mediated protein folding | 6.765593e-6 |
GO:0071310 | cellular response to organic substance | 7.162569e-6 |
GO:0031325 | positive regulation of cellular metabolic process | 7.193361e-6 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 7.242978e-6 |
GO:0090316 | positive regulation of intracellular protein transport | 7.306346e-6 |
GO:0072077 | renal vesicle morphogenesis | 7.516001e-6 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 7.733595e-6 |
GO:0046530 | photoreceptor cell differentiation | 7.855405e-6 |
GO:0034123 | positive regulation of toll-like receptor signaling pathway | 8.008342e-6 |
GO:0051216 | cartilage development | 8.272564e-6 |
GO:0002237 | response to molecule of bacterial origin | 8.278290e-6 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 8.417058e-6 |
GO:0051707 | response to other organism | 9.619862e-6 |
GO:0034121 | regulation of toll-like receptor signaling pathway | 9.798442e-6 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 1.021767e-5 |
GO:0007155 | cell adhesion | 1.089791e-5 |
GO:0002573 | myeloid leukocyte differentiation | 1.092919e-5 |
GO:0071705 | nitrogen compound transport | 1.240882e-5 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.270426e-5 |
GO:0048013 | ephrin receptor signaling pathway | 1.280608e-5 |
GO:0045923 | positive regulation of fatty acid metabolic process | 1.283909e-5 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 1.430211e-5 |
GO:0072087 | renal vesicle development | 1.468116e-5 |
GO:0033081 | regulation of T cell differentiation in thymus | 1.503726e-5 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.562228e-5 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 1.616614e-5 |
GO:0071495 | cellular response to endogenous stimulus | 1.649703e-5 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 1.789841e-5 |
GO:0007610 | behavior | 1.846049e-5 |
GO:0031329 | regulation of cellular catabolic process | 1.854353e-5 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 2.032549e-5 |
GO:2000026 | regulation of multicellular organismal development | 2.079590e-5 |
GO:0055094 | response to lipoprotein stimulus | 2.172487e-5 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 2.272668e-5 |
GO:0072273 | metanephric nephron morphogenesis | 2.283049e-5 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.326662e-5 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.346655e-5 |
GO:0008589 | regulation of smoothened signaling pathway | 2.359122e-5 |
GO:0009607 | response to biotic stimulus | 2.439624e-5 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 2.481247e-5 |
GO:0001101 | response to acid | 2.514786e-5 |
GO:0060326 | cell chemotaxis | 2.559018e-5 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 2.579221e-5 |
GO:0007218 | neuropeptide signaling pathway | 2.604035e-5 |
GO:0032463 | negative regulation of protein homooligomerization | 2.737464e-5 |
GO:0001501 | skeletal system development | 2.927889e-5 |
GO:0045666 | positive regulation of neuron differentiation | 3.198310e-5 |
GO:0048523 | negative regulation of cellular process | 3.224703e-5 |
GO:0030520 | estrogen receptor signaling pathway | 3.226682e-5 |
GO:0048771 | tissue remodeling | 3.227101e-5 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 3.280986e-5 |
GO:0071674 | mononuclear cell migration | 3.536696e-5 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 3.547326e-5 |
GO:0001562 | response to protozoan | 3.728786e-5 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 3.773085e-5 |
GO:0032501 | multicellular organismal process | 3.805708e-5 |
GO:0019217 | regulation of fatty acid metabolic process | 3.809884e-5 |
GO:0061138 | morphogenesis of a branching epithelium | 3.966662e-5 |
GO:0042306 | regulation of protein import into nucleus | 4.103357e-5 |
GO:0045765 | regulation of angiogenesis | 4.137306e-5 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 4.369101e-5 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 4.750574e-5 |
GO:0001672 | regulation of chromatin assembly or disassembly | 4.751444e-5 |
GO:0010629 | negative regulation of gene expression | 4.756271e-5 |
GO:0048513 | organ development | 4.832208e-5 |
GO:0003338 | metanephros morphogenesis | 4.910277e-5 |
GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway | 4.954850e-5 |
GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity | 5.151327e-5 |
GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway | 5.151327e-5 |
GO:0001763 | morphogenesis of a branching structure | 5.210715e-5 |
GO:0001659 | temperature homeostasis | 5.326530e-5 |
GO:0072221 | metanephric distal convoluted tubule development | 5.590407e-5 |
GO:0019915 | lipid storage | 5.598043e-5 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 5.687585e-5 |
GO:0051240 | positive regulation of multicellular organismal process | 5.868313e-5 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 5.964037e-5 |
GO:0051239 | regulation of multicellular organismal process | 5.981742e-5 |
GO:0050900 | leukocyte migration | 6.255242e-5 |
GO:0031998 | regulation of fatty acid beta-oxidation | 6.258141e-5 |
GO:0015816 | glycine transport | 6.269874e-5 |
GO:0050935 | iridophore differentiation | 6.393824e-5 |
GO:0048937 | lateral line nerve glial cell development | 6.393824e-5 |
GO:0072282 | metanephric nephron tubule morphogenesis | 6.401652e-5 |
GO:0048511 | rhythmic process | 6.428736e-5 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 6.450717e-5 |
GO:0007399 | nervous system development | 6.559057e-5 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 6.610325e-5 |
GO:2000611 | positive regulation of thyroid hormone generation | 6.673958e-5 |
GO:0030155 | regulation of cell adhesion | 7.025916e-5 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 7.144256e-5 |
GO:0060442 | branching involved in prostate gland morphogenesis | 7.146662e-5 |
GO:0015696 | ammonium transport | 7.481288e-5 |
GO:0007264 | small GTPase mediated signal transduction | 7.528156e-5 |
GO:0045059 | positive thymic T cell selection | 7.812112e-5 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 7.864692e-5 |
GO:0032365 | intracellular lipid transport | 7.923582e-5 |
GO:0034097 | response to cytokine stimulus | 7.992346e-5 |
GO:0072088 | nephron epithelium morphogenesis | 8.153344e-5 |
GO:0010171 | body morphogenesis | 8.363207e-5 |
GO:0032963 | collagen metabolic process | 8.392577e-5 |
GO:0009187 | cyclic nucleotide metabolic process | 8.412923e-5 |
GO:0072289 | metanephric nephron tubule formation | 8.582591e-5 |
GO:0046068 | cGMP metabolic process | 8.708360e-5 |
GO:0032462 | regulation of protein homooligomerization | 9.060703e-5 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 9.810480e-5 |
GO:0030185 | nitric oxide transport | 1.029482e-4 |
GO:0009896 | positive regulation of catabolic process | 1.029752e-4 |
GO:0010042 | response to manganese ion | 1.035937e-4 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1.060134e-4 |
GO:0001944 | vasculature development | 1.061478e-4 |
GO:0032388 | positive regulation of intracellular transport | 1.071072e-4 |
GO:0006954 | inflammatory response | 1.075602e-4 |
GO:0010508 | positive regulation of autophagy | 1.086824e-4 |
GO:0045087 | innate immune response | 1.089545e-4 |
GO:0030878 | thyroid gland development | 1.102796e-4 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 1.122557e-4 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 1.136283e-4 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.145963e-4 |
GO:0002694 | regulation of leukocyte activation | 1.156040e-4 |
GO:0034505 | tooth mineralization | 1.167539e-4 |
GO:0042221 | response to chemical stimulus | 1.174337e-4 |
GO:0051253 | negative regulation of RNA metabolic process | 1.191938e-4 |
GO:0045163 | clustering of voltage-gated potassium channels | 1.196384e-4 |
GO:0035148 | tube formation | 1.205617e-4 |
GO:0032526 | response to retinoic acid | 1.231317e-4 |
GO:0009725 | response to hormone stimulus | 1.267342e-4 |
GO:0045834 | positive regulation of lipid metabolic process | 1.302352e-4 |
GO:0043555 | regulation of translation in response to stress | 1.342898e-4 |
GO:0010470 | regulation of gastrulation | 1.358093e-4 |
GO:0050996 | positive regulation of lipid catabolic process | 1.359767e-4 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 1.367350e-4 |
GO:0042990 | regulation of transcription factor import into nucleus | 1.382296e-4 |
GO:0040023 | establishment of nucleus localization | 1.400170e-4 |
GO:0040011 | locomotion | 1.411318e-4 |
GO:0042832 | defense response to protozoan | 1.479766e-4 |
GO:0002064 | epithelial cell development | 1.483804e-4 |
GO:0060429 | epithelium development | 1.487020e-4 |
GO:0015837 | amine transport | 1.490327e-4 |
GO:0071359 | cellular response to dsRNA | 1.506104e-4 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 1.514351e-4 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 1.514351e-4 |
GO:0039003 | pronephric field specification | 1.514351e-4 |
GO:0006853 | carnitine shuttle | 1.527332e-4 |
GO:0009651 | response to salt stress | 1.574078e-4 |
GO:0009190 | cyclic nucleotide biosynthetic process | 1.625902e-4 |
GO:0060688 | regulation of morphogenesis of a branching structure | 1.629023e-4 |
GO:0002252 | immune effector process | 1.649420e-4 |
GO:0021570 | rhombomere 4 development | 1.697460e-4 |
GO:0007267 | cell-cell signaling | 1.723703e-4 |
GO:0001773 | myeloid dendritic cell activation | 1.728768e-4 |
GO:0009719 | response to endogenous stimulus | 1.734493e-4 |
GO:0033619 | membrane protein proteolysis | 1.765303e-4 |
GO:0060676 | ureteric bud formation | 1.804306e-4 |
GO:0050865 | regulation of cell activation | 1.825073e-4 |
GO:0033026 | negative regulation of mast cell apoptosis | 1.835456e-4 |
GO:0009645 | response to low light intensity stimulus | 1.846275e-4 |
GO:0046690 | response to tellurium ion | 1.846275e-4 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 1.852782e-4 |
GO:0046822 | regulation of nucleocytoplasmic transport | 1.877227e-4 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1.907258e-4 |
GO:0071637 | regulation of monocyte chemotactic protein-1 production | 1.936791e-4 |
GO:0050794 | regulation of cellular process | 1.944771e-4 |
GO:0001568 | blood vessel development | 1.951746e-4 |
GO:0019216 | regulation of lipid metabolic process | 2.011626e-4 |
GO:0050867 | positive regulation of cell activation | 2.018409e-4 |
GO:0009890 | negative regulation of biosynthetic process | 2.052994e-4 |
GO:0022407 | regulation of cell-cell adhesion | 2.062725e-4 |
GO:0050994 | regulation of lipid catabolic process | 2.113846e-4 |
GO:0009894 | regulation of catabolic process | 2.217582e-4 |
GO:0002673 | regulation of acute inflammatory response | 2.261738e-4 |
GO:0010939 | regulation of necrotic cell death | 2.282680e-4 |
GO:0010829 | negative regulation of glucose transport | 2.301400e-4 |
GO:0030856 | regulation of epithelial cell differentiation | 2.312207e-4 |
GO:0045916 | negative regulation of complement activation | 2.348704e-4 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 2.417405e-4 |
GO:0002696 | positive regulation of leukocyte activation | 2.422817e-4 |
GO:0048645 | organ formation | 2.426051e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 2.447600e-4 |
GO:0015887 | pantothenate transmembrane transport | 2.456381e-4 |
GO:0016598 | protein arginylation | 2.456381e-4 |
GO:0015878 | biotin transport | 2.456381e-4 |
GO:0048731 | system development | 2.460622e-4 |
GO:0043009 | chordate embryonic development | 2.464387e-4 |
GO:0001838 | embryonic epithelial tube formation | 2.477141e-4 |
GO:0002828 | regulation of type 2 immune response | 2.496856e-4 |
GO:0014048 | regulation of glutamate secretion | 2.498135e-4 |
GO:0048534 | hemopoietic or lymphoid organ development | 2.498658e-4 |
GO:0042462 | eye photoreceptor cell development | 2.549162e-4 |
GO:0045861 | negative regulation of proteolysis | 2.565998e-4 |
GO:0042127 | regulation of cell proliferation | 2.567195e-4 |
GO:0001655 | urogenital system development | 2.621680e-4 |
GO:0009605 | response to external stimulus | 2.631459e-4 |
GO:0048671 | negative regulation of collateral sprouting | 2.683589e-4 |
GO:0072234 | metanephric nephron tubule development | 2.737498e-4 |
GO:0060405 | regulation of penile erection | 2.759575e-4 |
GO:0032543 | mitochondrial translation | 2.787598e-4 |
GO:0032270 | positive regulation of cellular protein metabolic process | 2.794558e-4 |
GO:0051247 | positive regulation of protein metabolic process | 2.815566e-4 |
GO:0030850 | prostate gland development | 2.830153e-4 |
GO:0035279 | mRNA cleavage involved in gene silencing by miRNA | 2.835578e-4 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 2.884310e-4 |
GO:0071345 | cellular response to cytokine stimulus | 2.917517e-4 |
GO:0034612 | response to tumor necrosis factor | 2.943751e-4 |
GO:0009967 | positive regulation of signal transduction | 2.950476e-4 |
GO:0040040 | thermosensory behavior | 2.983146e-4 |
GO:0010977 | negative regulation of neuron projection development | 2.989505e-4 |
GO:0043401 | steroid hormone mediated signaling pathway | 2.990405e-4 |
GO:0031960 | response to corticosteroid stimulus | 3.033179e-4 |
GO:0060992 | response to fungicide | 3.044633e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.103171e-4 |
GO:0002520 | immune system development | 3.131897e-4 |
GO:0010761 | fibroblast migration | 3.155632e-4 |
GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response | 3.155979e-4 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 3.157797e-4 |
GO:0015804 | neutral amino acid transport | 3.305048e-4 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 3.418900e-4 |
GO:0001657 | ureteric bud development | 3.457535e-4 |
GO:0010941 | regulation of cell death | 3.571341e-4 |
GO:0072003 | kidney rudiment formation | 3.621635e-4 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 3.655155e-4 |
GO:0003180 | aortic valve morphogenesis | 3.714727e-4 |
GO:0010871 | negative regulation of receptor biosynthetic process | 3.804270e-4 |
GO:0002684 | positive regulation of immune system process | 3.821675e-4 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 3.848907e-4 |
GO:0048709 | oligodendrocyte differentiation | 3.946163e-4 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 3.992127e-4 |
GO:0072170 | metanephric tubule development | 3.999833e-4 |
GO:0046836 | glycolipid transport | 4.006371e-4 |
GO:0021546 | rhombomere development | 4.075323e-4 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.123059e-4 |
GO:0048754 | branching morphogenesis of a tube | 4.231404e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 4.252600e-4 |
GO:0090183 | regulation of kidney development | 4.324021e-4 |
GO:0048519 | negative regulation of biological process | 4.347648e-4 |
GO:0002437 | inflammatory response to antigenic stimulus | 4.360644e-4 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 4.362704e-4 |
GO:0009649 | entrainment of circadian clock | 4.400689e-4 |
GO:0032332 | positive regulation of chondrocyte differentiation | 4.466184e-4 |
GO:0002521 | leukocyte differentiation | 4.578235e-4 |
GO:0045672 | positive regulation of osteoclast differentiation | 4.707922e-4 |
GO:0015879 | carnitine transport | 4.720619e-4 |
GO:0051222 | positive regulation of protein transport | 4.723659e-4 |
GO:0014070 | response to organic cyclic compound | 4.750016e-4 |
GO:0030097 | hemopoiesis | 4.772866e-4 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 4.798064e-4 |
GO:0032673 | regulation of interleukin-4 production | 4.875623e-4 |
GO:0044130 | negative regulation of growth of symbiont in host | 4.885249e-4 |
GO:0070842 | aggresome assembly | 4.986170e-4 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 5.061908e-4 |
GO:0060373 | regulation of ventricular cardiomyocyte membrane depolarization | 5.061908e-4 |
GO:0009642 | response to light intensity | 5.129212e-4 |
GO:0030522 | intracellular receptor mediated signaling pathway | 5.139361e-4 |
GO:0050852 | T cell receptor signaling pathway | 5.193477e-4 |
GO:0033157 | regulation of intracellular protein transport | 5.210291e-4 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 5.245020e-4 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 5.245020e-4 |
GO:0014015 | positive regulation of gliogenesis | 5.297617e-4 |
GO:0001958 | endochondral ossification | 5.361784e-4 |
GO:0032330 | regulation of chondrocyte differentiation | 5.386353e-4 |
GO:0071639 | positive regulation of monocyte chemotactic protein-1 production | 5.392648e-4 |
GO:0010715 | regulation of extracellular matrix disassembly | 5.428767e-4 |
GO:0032722 | positive regulation of chemokine production | 5.525353e-4 |
GO:0060325 | face morphogenesis | 5.541473e-4 |
GO:0042220 | response to cocaine | 5.565134e-4 |
GO:0043011 | myeloid dendritic cell differentiation | 5.715638e-4 |
GO:0045595 | regulation of cell differentiation | 5.723455e-4 |
GO:0010565 | regulation of cellular ketone metabolic process | 5.751908e-4 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 5.802488e-4 |
GO:0071360 | cellular response to exogenous dsRNA | 5.852147e-4 |
GO:0050778 | positive regulation of immune response | 5.909175e-4 |
GO:0042981 | regulation of apoptosis | 5.911259e-4 |
GO:0072148 | epithelial cell fate commitment | 5.931482e-4 |
GO:0008284 | positive regulation of cell proliferation | 5.986467e-4 |
GO:0072009 | nephron epithelium development | 5.988655e-4 |
GO:0006448 | regulation of translational elongation | 5.989543e-4 |
GO:0072028 | nephron morphogenesis | 6.013803e-4 |
GO:0035239 | tube morphogenesis | 6.020205e-4 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 6.035971e-4 |
GO:0060056 | mammary gland involution | 6.143377e-4 |
GO:0071460 | cellular response to cell-matrix adhesion | 6.211350e-4 |
GO:0042461 | photoreceptor cell development | 6.318198e-4 |
GO:0007602 | phototransduction | 6.336168e-4 |
GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching | 6.346923e-4 |
GO:0010883 | regulation of lipid storage | 6.358996e-4 |
GO:0045880 | positive regulation of smoothened signaling pathway | 6.492142e-4 |
GO:0032880 | regulation of protein localization | 6.640612e-4 |
GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 6.696038e-4 |
GO:0051454 | intracellular pH elevation | 6.868722e-4 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 6.885371e-4 |
GO:0060406 | positive regulation of penile erection | 6.952779e-4 |
GO:0033089 | positive regulation of T cell differentiation in thymus | 6.987585e-4 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 6.994398e-4 |
GO:0072175 | epithelial tube formation | 7.055978e-4 |
GO:0061035 | regulation of cartilage development | 7.142778e-4 |
GO:0031223 | auditory behavior | 7.425047e-4 |
GO:0048692 | negative regulation of axon extension involved in regeneration | 7.443886e-4 |
GO:0007225 | patched ligand maturation | 7.443886e-4 |
GO:0071300 | cellular response to retinoic acid | 7.490576e-4 |
GO:0009792 | embryo development ending in birth or egg hatching | 7.498239e-4 |
GO:0019882 | antigen processing and presentation | 7.547585e-4 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 7.694238e-4 |
GO:0060562 | epithelial tube morphogenesis | 7.744015e-4 |
GO:0021602 | cranial nerve morphogenesis | 7.819309e-4 |
GO:0045061 | thymic T cell selection | 7.899115e-4 |
GO:0070668 | positive regulation of mast cell proliferation | 7.949513e-4 |
GO:0071299 | cellular response to vitamin A | 7.986649e-4 |
GO:0006768 | biotin metabolic process | 8.007493e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 8.100178e-4 |
GO:0009755 | hormone-mediated signaling pathway | 8.128197e-4 |
GO:0006865 | amino acid transport | 8.134045e-4 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 8.508978e-4 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 8.581180e-4 |
GO:0046168 | glycerol-3-phosphate catabolic process | 8.685839e-4 |
GO:0032964 | collagen biosynthetic process | 8.688243e-4 |
GO:0015908 | fatty acid transport | 8.698557e-4 |
GO:0031401 | positive regulation of protein modification process | 8.710151e-4 |
GO:0045073 | regulation of chemokine biosynthetic process | 8.775191e-4 |
GO:0034447 | very-low-density lipoprotein particle clearance | 8.810852e-4 |
GO:0035112 | genitalia morphogenesis | 8.824725e-4 |
GO:0030518 | steroid hormone receptor signaling pathway | 8.869024e-4 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 8.937857e-4 |
GO:0016331 | morphogenesis of embryonic epithelium | 8.973364e-4 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 8.993723e-4 |
GO:0072210 | metanephric nephron development | 9.011719e-4 |
GO:0034341 | response to interferon-gamma | 9.015241e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 9.020244e-4 |
GO:0060675 | ureteric bud morphogenesis | 9.066442e-4 |
GO:0015697 | quaternary ammonium group transport | 9.096975e-4 |
GO:0071276 | cellular response to cadmium ion | 9.152689e-4 |
GO:0048536 | spleen development | 9.225360e-4 |
GO:0045766 | positive regulation of angiogenesis | 9.312915e-4 |
GO:0071481 | cellular response to X-ray | 9.329798e-4 |
GO:0032459 | regulation of protein oligomerization | 9.375419e-4 |
GO:0007274 | neuromuscular synaptic transmission | 9.420644e-4 |
GO:0060323 | head morphogenesis | 9.433024e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 9.554441e-4 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 9.632561e-4 |
GO:0045058 | T cell selection | 9.762782e-4 |
GO:0007568 | aging | 9.771057e-4 |
GO:0071280 | cellular response to copper ion | 9.839074e-4 |
GO:0010605 | negative regulation of macromolecule metabolic process | 9.876882e-4 |
GO:0060547 | negative regulation of necrotic cell death | 1.004806e-3 |
GO:0001831 | trophectodermal cellular morphogenesis | 1.004806e-3 |
GO:0030595 | leukocyte chemotaxis | 1.005907e-3 |
GO:0002253 | activation of immune response | 1.024135e-3 |
GO:0043067 | regulation of programmed cell death | 1.027424e-3 |
GO:2000736 | regulation of stem cell differentiation | 1.032893e-3 |
GO:0051254 | positive regulation of RNA metabolic process | 1.037387e-3 |
GO:0060516 | primary prostatic bud elongation | 1.039730e-3 |
GO:0060284 | regulation of cell development | 1.044040e-3 |
GO:0071383 | cellular response to steroid hormone stimulus | 1.053533e-3 |
GO:0048856 | anatomical structure development | 1.068819e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.068997e-3 |
GO:0021545 | cranial nerve development | 1.069931e-3 |
GO:0043279 | response to alkaloid | 1.079451e-3 |
GO:0032410 | negative regulation of transporter activity | 1.085337e-3 |
GO:0051066 | dihydrobiopterin metabolic process | 1.106881e-3 |
GO:0032314 | regulation of Rac GTPase activity | 1.123087e-3 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.130098e-3 |
GO:0009409 | response to cold | 1.142897e-3 |
GO:0035767 | endothelial cell chemotaxis | 1.174906e-3 |
GO:0051013 | microtubule severing | 1.187570e-3 |
GO:0060356 | leucine import | 1.187570e-3 |
GO:0001823 | mesonephros development | 1.192493e-3 |
GO:0003417 | growth plate cartilage development | 1.195316e-3 |
GO:0048729 | tissue morphogenesis | 1.216214e-3 |
GO:0032663 | regulation of interleukin-2 production | 1.222577e-3 |
GO:0072006 | nephron development | 1.223735e-3 |
GO:0072387 | flavin adenine dinucleotide metabolic process | 1.261873e-3 |
GO:0009956 | radial pattern formation | 1.278818e-3 |
GO:0060662 | salivary gland cavitation | 1.312707e-3 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.328119e-3 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.336161e-3 |
GO:0019087 | transformation of host cell by virus | 1.337050e-3 |
GO:0001543 | ovarian follicle rupture | 1.337050e-3 |
GO:0014050 | negative regulation of glutamate secretion | 1.337542e-3 |
GO:0046324 | regulation of glucose import | 1.341465e-3 |
GO:0032386 | regulation of intracellular transport | 1.342675e-3 |
GO:0006004 | fucose metabolic process | 1.342896e-3 |
GO:0010885 | regulation of cholesterol storage | 1.344297e-3 |
GO:0043313 | regulation of neutrophil degranulation | 1.345255e-3 |
GO:0032438 | melanosome organization | 1.381186e-3 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 1.383302e-3 |
GO:0003416 | endochondral bone growth | 1.387527e-3 |
GO:0042759 | long-chain fatty acid biosynthetic process | 1.391165e-3 |
GO:0043312 | neutrophil degranulation | 1.404525e-3 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 1.442848e-3 |
GO:0032713 | negative regulation of interleukin-4 production | 1.443229e-3 |
GO:0015909 | long-chain fatty acid transport | 1.449751e-3 |
GO:0072205 | metanephric collecting duct development | 1.452415e-3 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 1.459232e-3 |
GO:0008616 | queuosine biosynthetic process | 1.459232e-3 |
GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1.462767e-3 |
GO:0071503 | response to heparin | 1.488859e-3 |
GO:0048545 | response to steroid hormone stimulus | 1.513054e-3 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 1.537870e-3 |
GO:0071985 | multivesicular body sorting pathway | 1.537870e-3 |
GO:0050793 | regulation of developmental process | 1.539677e-3 |
GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway | 1.557309e-3 |
GO:0010501 | RNA secondary structure unwinding | 1.569124e-3 |
GO:0065007 | biological regulation | 1.599678e-3 |
GO:0030574 | collagen catabolic process | 1.602806e-3 |
GO:0006198 | cAMP catabolic process | 1.610098e-3 |
GO:0019405 | alditol catabolic process | 1.622194e-3 |
GO:0070201 | regulation of establishment of protein localization | 1.624214e-3 |
GO:0048753 | pigment granule organization | 1.627125e-3 |
GO:0043017 | positive regulation of lymphotoxin A biosynthetic process | 1.634714e-3 |
GO:0002921 | negative regulation of humoral immune response | 1.643156e-3 |
GO:0009123 | nucleoside monophosphate metabolic process | 1.648273e-3 |
GO:0002070 | epithelial cell maturation | 1.651817e-3 |
GO:0007501 | mesodermal cell fate specification | 1.670675e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0032879 | regulation of localization | 8.239462e-10 |
GO:0030799 | regulation of cyclic nucleotide metabolic process | 1.511920e-9 |
GO:0043462 | regulation of ATPase activity | 2.185541e-9 |
GO:0003208 | cardiac ventricle morphogenesis | 2.902785e-9 |
GO:0030049 | muscle filament sliding | 3.319892e-9 |
GO:0007522 | visceral muscle development | 6.744030e-9 |
GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 8.595344e-9 |
GO:0040013 | negative regulation of locomotion | 1.267219e-8 |
GO:0045762 | positive regulation of adenylate cyclase activity | 2.404671e-8 |
GO:0045761 | regulation of adenylate cyclase activity | 2.770990e-8 |
GO:0003229 | ventricular cardiac muscle tissue development | 2.794433e-8 |
GO:0010769 | regulation of cell morphogenesis involved in differentiation | 2.942115e-8 |
GO:0071260 | cellular response to mechanical stimulus | 3.688650e-8 |
GO:0031281 | positive regulation of cyclase activity | 5.130152e-8 |
GO:0051270 | regulation of cellular component movement | 5.558125e-8 |
GO:0040012 | regulation of locomotion | 6.762315e-8 |
GO:0030539 | male genitalia development | 6.822976e-8 |
GO:0048813 | dendrite morphogenesis | 6.876509e-8 |
GO:0022603 | regulation of anatomical structure morphogenesis | 8.801994e-8 |
GO:0007190 | activation of adenylate cyclase activity | 9.095934e-8 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.231387e-7 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 1.233047e-7 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.411200e-7 |
GO:0032642 | regulation of chemokine production | 1.667894e-7 |
GO:0050896 | response to stimulus | 1.887568e-7 |
GO:0031279 | regulation of cyclase activity | 1.983274e-7 |
GO:0030817 | regulation of cAMP biosynthetic process | 1.984243e-7 |
GO:0048806 | genitalia development | 2.343405e-7 |
GO:0003206 | cardiac chamber morphogenesis | 2.583831e-7 |
GO:0007166 | cell surface receptor linked signaling pathway | 2.777995e-7 |
GO:0030155 | regulation of cell adhesion | 3.311518e-7 |
GO:2000145 | regulation of cell motility | 3.372909e-7 |
GO:0051349 | positive regulation of lyase activity | 3.405707e-7 |
GO:2000146 | negative regulation of cell motility | 3.590850e-7 |
GO:0009187 | cyclic nucleotide metabolic process | 3.937966e-7 |
GO:0030814 | regulation of cAMP metabolic process | 4.093717e-7 |
GO:0030334 | regulation of cell migration | 4.271774e-7 |
GO:0006140 | regulation of nucleotide metabolic process | 5.101948e-7 |
GO:0060346 | bone trabecula formation | 5.296617e-7 |
GO:0050794 | regulation of cellular process | 5.545917e-7 |
GO:0071496 | cellular response to external stimulus | 5.710673e-7 |
GO:0050920 | regulation of chemotaxis | 6.184098e-7 |
GO:0070887 | cellular response to chemical stimulus | 6.989176e-7 |
GO:0051339 | regulation of lyase activity | 8.541223e-7 |
GO:0051271 | negative regulation of cellular component movement | 8.592787e-7 |
GO:0050771 | negative regulation of axonogenesis | 1.008025e-6 |
GO:0050770 | regulation of axonogenesis | 1.045441e-6 |
GO:0007154 | cell communication | 1.053959e-6 |
GO:0030336 | negative regulation of cell migration | 1.209084e-6 |
GO:0050795 | regulation of behavior | 1.312180e-6 |
GO:0022604 | regulation of cell morphogenesis | 1.360488e-6 |
GO:0034097 | response to cytokine stimulus | 1.470805e-6 |
GO:0007189 | activation of adenylate cyclase activity by G-protein signaling pathway | 1.561889e-6 |
GO:0002684 | positive regulation of immune system process | 1.808559e-6 |
GO:0032963 | collagen metabolic process | 1.912664e-6 |
GO:0003231 | cardiac ventricle development | 2.132987e-6 |
GO:0070848 | response to growth factor stimulus | 2.355592e-6 |
GO:0003209 | cardiac atrium morphogenesis | 2.390232e-6 |
GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | 2.420657e-6 |
GO:0003230 | cardiac atrium development | 2.469369e-6 |
GO:0010812 | negative regulation of cell-substrate adhesion | 2.670457e-6 |
GO:0070208 | protein heterotrimerization | 2.753469e-6 |
GO:0002376 | immune system process | 2.824462e-6 |
GO:0071214 | cellular response to abiotic stimulus | 2.857392e-6 |
GO:0030825 | positive regulation of cGMP metabolic process | 2.922962e-6 |
GO:0045113 | regulation of integrin biosynthetic process | 3.072599e-6 |
GO:0032103 | positive regulation of response to external stimulus | 3.077575e-6 |
GO:0018879 | biphenyl metabolic process | 3.199773e-6 |
GO:0051049 | regulation of transport | 3.343656e-6 |
GO:0030098 | lymphocyte differentiation | 3.735908e-6 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 4.122277e-6 |
GO:0003205 | cardiac chamber development | 4.925633e-6 |
GO:0014052 | regulation of gamma-aminobutyric acid secretion | 5.331669e-6 |
GO:0006928 | cellular component movement | 5.337118e-6 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 5.340552e-6 |
GO:0051716 | cellular response to stimulus | 5.657409e-6 |
GO:0055008 | cardiac muscle tissue morphogenesis | 6.058314e-6 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 6.194311e-6 |
GO:0048841 | regulation of axon extension involved in axon guidance | 6.227103e-6 |
GO:0009190 | cyclic nucleotide biosynthetic process | 6.413210e-6 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 6.417319e-6 |
GO:0009605 | response to external stimulus | 6.460267e-6 |
GO:0032793 | positive regulation of CREB transcription factor activity | 6.934397e-6 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 8.478652e-6 |
GO:0007129 | synapsis | 8.671057e-6 |
GO:0048539 | bone marrow development | 8.938380e-6 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 9.269506e-6 |
GO:0009612 | response to mechanical stimulus | 9.684829e-6 |
GO:0023052 | signaling | 9.958873e-6 |
GO:0046058 | cAMP metabolic process | 1.018470e-5 |
GO:0009956 | radial pattern formation | 1.026265e-5 |
GO:0032880 | regulation of protein localization | 1.051351e-5 |
GO:0021952 | central nervous system projection neuron axonogenesis | 1.113192e-5 |
GO:0016601 | Rac protein signal transduction | 1.147003e-5 |
GO:0045321 | leukocyte activation | 1.177532e-5 |
GO:0050776 | regulation of immune response | 1.185325e-5 |
GO:0030641 | regulation of cellular pH | 1.286130e-5 |
GO:0002906 | negative regulation of mature B cell apoptosis | 1.298715e-5 |
GO:0070192 | chromosome organization involved in meiosis | 1.328267e-5 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1.375610e-5 |
GO:0032501 | multicellular organismal process | 1.400418e-5 |
GO:0016477 | cell migration | 1.586281e-5 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.847057e-5 |
GO:0009617 | response to bacterium | 1.917136e-5 |
GO:0048522 | positive regulation of cellular process | 2.000005e-5 |
GO:0042221 | response to chemical stimulus | 2.104231e-5 |
GO:0016358 | dendrite development | 2.142147e-5 |
GO:0003215 | cardiac right ventricle morphogenesis | 2.174824e-5 |
GO:0051128 | regulation of cellular component organization | 2.223841e-5 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 2.308640e-5 |
GO:0050789 | regulation of biological process | 2.410043e-5 |
GO:0002237 | response to molecule of bacterial origin | 2.558966e-5 |
GO:0008582 | regulation of synaptic growth at neuromuscular junction | 2.625509e-5 |
GO:0007165 | signal transduction | 2.793932e-5 |
GO:0055093 | response to hyperoxia | 2.961403e-5 |
GO:0006909 | phagocytosis | 2.973001e-5 |
GO:0006116 | NADH oxidation | 2.986485e-5 |
GO:0032677 | regulation of interleukin-8 production | 3.135749e-5 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 3.173862e-5 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 3.262760e-5 |
GO:0042758 | long-chain fatty acid catabolic process | 3.331216e-5 |
GO:0042413 | carnitine catabolic process | 3.331216e-5 |
GO:0045346 | regulation of MHC class II biosynthetic process | 3.400633e-5 |
GO:0002697 | regulation of immune effector process | 3.600997e-5 |
GO:0051050 | positive regulation of transport | 3.641887e-5 |
GO:0010033 | response to organic substance | 3.644842e-5 |
GO:0040011 | locomotion | 3.875046e-5 |
GO:0030217 | T cell differentiation | 3.881126e-5 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 3.883589e-5 |
GO:0035556 | intracellular signal transduction | 4.089199e-5 |
GO:0045073 | regulation of chemokine biosynthetic process | 4.378848e-5 |
GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 4.458190e-5 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 4.520754e-5 |
GO:2000353 | positive regulation of endothelial cell apoptosis | 4.840548e-5 |
GO:0051094 | positive regulation of developmental process | 5.090016e-5 |
GO:0019724 | B cell mediated immunity | 5.114020e-5 |
GO:0060907 | positive regulation of macrophage cytokine production | 5.126281e-5 |
GO:0007413 | axonal fasciculation | 5.230137e-5 |
GO:0016338 | calcium-independent cell-cell adhesion | 5.462324e-5 |
GO:0050778 | positive regulation of immune response | 5.465847e-5 |
GO:0046483 | heterocycle metabolic process | 5.716591e-5 |
GO:0048518 | positive regulation of biological process | 5.756879e-5 |
GO:0048869 | cellular developmental process | 5.761605e-5 |
GO:0007029 | endoplasmic reticulum organization | 5.778397e-5 |
GO:0046649 | lymphocyte activation | 5.829575e-5 |
GO:0032496 | response to lipopolysaccharide | 6.061889e-5 |
GO:0061138 | morphogenesis of a branching epithelium | 6.284064e-5 |
GO:0065007 | biological regulation | 6.364397e-5 |
GO:0007130 | synaptonemal complex assembly | 6.364904e-5 |
GO:0021602 | cranial nerve morphogenesis | 6.375913e-5 |
GO:0035803 | egg coat formation | 6.833507e-5 |
GO:0006702 | androgen biosynthetic process | 6.857958e-5 |
GO:0050867 | positive regulation of cell activation | 6.922302e-5 |
GO:0030154 | cell differentiation | 7.147535e-5 |
GO:0050922 | negative regulation of chemotaxis | 7.215141e-5 |
GO:0009123 | nucleoside monophosphate metabolic process | 7.230368e-5 |
GO:0014067 | negative regulation of phosphatidylinositol 3-kinase cascade | 7.489046e-5 |
GO:0006955 | immune response | 7.645284e-5 |
GO:0050921 | positive regulation of chemotaxis | 7.893392e-5 |
GO:0030855 | epithelial cell differentiation | 8.029962e-5 |
GO:0035621 | ER to Golgi ceramide transport | 8.422778e-5 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 8.422778e-5 |
GO:0010959 | regulation of metal ion transport | 8.654887e-5 |
GO:0019933 | cAMP-mediated signaling | 8.796809e-5 |
GO:0048731 | system development | 8.813709e-5 |
GO:0016064 | immunoglobulin mediated immune response | 9.186877e-5 |
GO:0006917 | induction of apoptosis | 9.358049e-5 |
GO:0018963 | phthalate metabolic process | 9.530454e-5 |
GO:0009889 | regulation of biosynthetic process | 9.780697e-5 |
GO:0012502 | induction of programmed cell death | 9.898865e-5 |
GO:0080090 | regulation of primary metabolic process | 1.007516e-4 |
GO:0019541 | propionate metabolic process | 1.024678e-4 |
GO:0010596 | negative regulation of endothelial cell migration | 1.030849e-4 |
GO:0071732 | cellular response to nitric oxide | 1.034248e-4 |
GO:0048729 | tissue morphogenesis | 1.037160e-4 |
GO:0030823 | regulation of cGMP metabolic process | 1.042184e-4 |
GO:0030574 | collagen catabolic process | 1.057615e-4 |
GO:0032782 | bile acid secretion | 1.061986e-4 |
GO:0050928 | negative regulation of positive chemotaxis | 1.061986e-4 |
GO:0006285 | base-excision repair, AP site formation | 1.061986e-4 |
GO:0003096 | renal sodium ion transport | 1.061986e-4 |
GO:0032649 | regulation of interferon-gamma production | 1.085518e-4 |
GO:0060343 | trabecula formation | 1.095569e-4 |
GO:0002520 | immune system development | 1.111537e-4 |
GO:0010810 | regulation of cell-substrate adhesion | 1.201343e-4 |
GO:0032892 | positive regulation of organic acid transport | 1.231731e-4 |
GO:0002377 | immunoglobulin production | 1.241736e-4 |
GO:0002696 | positive regulation of leukocyte activation | 1.256560e-4 |
GO:0008038 | neuron recognition | 1.312580e-4 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 1.331198e-4 |
GO:0050877 | neurological system process | 1.360400e-4 |
GO:0019932 | second-messenger-mediated signaling | 1.384717e-4 |
GO:0048852 | diencephalon morphogenesis | 1.568173e-4 |
GO:0040017 | positive regulation of locomotion | 1.578292e-4 |
GO:0045359 | positive regulation of interferon-beta biosynthetic process | 1.592917e-4 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.655118e-4 |
GO:0001775 | cell activation | 1.657307e-4 |
GO:0043270 | positive regulation of ion transport | 1.676701e-4 |
GO:0043067 | regulation of programmed cell death | 1.696770e-4 |
GO:0048843 | negative regulation of axon extension involved in axon guidance | 1.697611e-4 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 1.752337e-4 |
GO:0007265 | Ras protein signal transduction | 1.896271e-4 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.936567e-4 |
GO:0044236 | multicellular organismal metabolic process | 1.953343e-4 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 1.957997e-4 |
GO:0010935 | regulation of macrophage cytokine production | 1.961998e-4 |
GO:0060070 | canonical Wnt receptor signaling pathway | 1.972084e-4 |
GO:0003008 | system process | 1.975595e-4 |
GO:0007254 | JNK cascade | 2.019341e-4 |
GO:0006145 | purine base catabolic process | 2.023945e-4 |
GO:2000147 | positive regulation of cell motility | 2.029794e-4 |
GO:0019227 | neuronal action potential propagation | 2.032769e-4 |
GO:0072521 | purine-containing compound metabolic process | 2.037360e-4 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 2.050950e-4 |
GO:0007517 | muscle organ development | 2.053043e-4 |
GO:0033275 | actin-myosin filament sliding | 2.084013e-4 |
GO:0031326 | regulation of cellular biosynthetic process | 2.100067e-4 |
GO:0009117 | nucleotide metabolic process | 2.148299e-4 |
GO:0009115 | xanthine catabolic process | 2.156553e-4 |
GO:0030048 | actin filament-based movement | 2.244793e-4 |
GO:0019543 | propionate catabolic process | 2.311506e-4 |
GO:0009607 | response to biotic stimulus | 2.391214e-4 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 2.408681e-4 |
GO:0071363 | cellular response to growth factor stimulus | 2.444738e-4 |
GO:0030198 | extracellular matrix organization | 2.448259e-4 |
GO:0032733 | positive regulation of interleukin-10 production | 2.510586e-4 |
GO:0015937 | coenzyme A biosynthetic process | 2.534883e-4 |
GO:0002449 | lymphocyte mediated immunity | 2.535872e-4 |
GO:2000008 | regulation of protein localization at cell surface | 2.591378e-4 |
GO:0048534 | hemopoietic or lymphoid organ development | 2.603358e-4 |
GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 2.614043e-4 |
GO:0043589 | skin morphogenesis | 2.673196e-4 |
GO:0048739 | cardiac muscle fiber development | 2.774616e-4 |
GO:0009063 | cellular amino acid catabolic process | 2.775574e-4 |
GO:0060429 | epithelium development | 2.827162e-4 |
GO:0048870 | cell motility | 2.852541e-4 |
GO:0035987 | endodermal cell differentiation | 2.881843e-4 |
GO:0007162 | negative regulation of cell adhesion | 2.909648e-4 |
GO:0032502 | developmental process | 2.938041e-4 |
GO:0002687 | positive regulation of leukocyte migration | 2.942313e-4 |
GO:0001503 | ossification | 3.009261e-4 |
GO:0071310 | cellular response to organic substance | 3.050481e-4 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 3.100238e-4 |
GO:0048521 | negative regulation of behavior | 3.109195e-4 |
GO:0051223 | regulation of protein transport | 3.169772e-4 |
GO:0070925 | organelle assembly | 3.182662e-4 |
GO:0042110 | T cell activation | 3.211174e-4 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 3.236633e-4 |
GO:0071731 | response to nitric oxide | 3.298277e-4 |
GO:0032972 | regulation of muscle filament sliding speed | 3.333358e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 3.333358e-4 |
GO:0045851 | pH reduction | 3.401764e-4 |
GO:0051272 | positive regulation of cellular component movement | 3.410826e-4 |
GO:0070201 | regulation of establishment of protein localization | 3.524046e-4 |
GO:0051452 | intracellular pH reduction | 3.544753e-4 |
GO:0018894 | dibenzo-p-dioxin metabolic process | 3.549962e-4 |
GO:0002921 | negative regulation of humoral immune response | 3.549962e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 3.549962e-4 |
GO:0044319 | wound healing, spreading of cells | 3.587443e-4 |
GO:0043148 | mitotic spindle stabilization | 3.595013e-4 |
GO:0060415 | muscle tissue morphogenesis | 3.643798e-4 |
GO:0002440 | production of molecular mediator of immune response | 3.676556e-4 |
GO:0014706 | striated muscle tissue development | 3.714513e-4 |
GO:0002902 | regulation of B cell apoptosis | 3.787157e-4 |
GO:0030097 | hemopoiesis | 3.840980e-4 |
GO:0031929 | TOR signaling cascade | 3.888228e-4 |
GO:0001944 | vasculature development | 3.935492e-4 |
GO:0042176 | regulation of protein catabolic process | 4.033018e-4 |
GO:0051480 | cytosolic calcium ion homeostasis | 4.067302e-4 |
GO:0060539 | diaphragm development | 4.132903e-4 |
GO:0019674 | NAD metabolic process | 4.151283e-4 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 4.194021e-4 |
GO:0009888 | tissue development | 4.216848e-4 |
GO:0022904 | respiratory electron transport chain | 4.252304e-4 |
GO:0048732 | gland development | 4.329636e-4 |
GO:0032890 | regulation of organic acid transport | 4.334033e-4 |
GO:0048812 | neuron projection morphogenesis | 4.367772e-4 |
GO:0006163 | purine nucleotide metabolic process | 4.447727e-4 |
GO:0032729 | positive regulation of interferon-gamma production | 4.500639e-4 |
GO:0001937 | negative regulation of endothelial cell proliferation | 4.507286e-4 |
GO:0030335 | positive regulation of cell migration | 4.609498e-4 |
GO:0051222 | positive regulation of protein transport | 4.630420e-4 |
GO:0042981 | regulation of apoptosis | 4.646452e-4 |
GO:0006734 | NADH metabolic process | 4.691208e-4 |
GO:0002521 | leukocyte differentiation | 4.738715e-4 |
GO:0035295 | tube development | 4.743223e-4 |
GO:0001714 | endodermal cell fate specification | 4.869856e-4 |
GO:0060236 | regulation of mitotic spindle organization | 4.879953e-4 |
GO:0015862 | uridine transport | 4.879953e-4 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 4.976214e-4 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 5.115842e-4 |
GO:0002443 | leukocyte mediated immunity | 5.206638e-4 |
GO:0051382 | kinetochore assembly | 5.219493e-4 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 5.245860e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 5.245860e-4 |
GO:0046168 | glycerol-3-phosphate catabolic process | 5.245860e-4 |
GO:0007356 | thorax and anterior abdomen determination | 5.245860e-4 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 5.475820e-4 |
GO:0032736 | positive regulation of interleukin-13 production | 5.475820e-4 |
GO:0031323 | regulation of cellular metabolic process | 5.531872e-4 |
GO:0010661 | positive regulation of muscle cell apoptosis | 5.605696e-4 |
GO:0035641 | locomotory exploration behavior | 5.670138e-4 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 5.730111e-4 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 5.741916e-4 |
GO:0048002 | antigen processing and presentation of peptide antigen | 5.744993e-4 |
GO:0006547 | histidine metabolic process | 5.800945e-4 |
GO:0051282 | regulation of sequestering of calcium ion | 5.941730e-4 |
GO:0030858 | positive regulation of epithelial cell differentiation | 5.942452e-4 |
GO:0001501 | skeletal system development | 6.015390e-4 |
GO:0050865 | regulation of cell activation | 6.063218e-4 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 6.079187e-4 |
GO:0048513 | organ development | 6.102774e-4 |
GO:0043484 | regulation of RNA splicing | 6.132867e-4 |
GO:0006805 | xenobiotic metabolic process | 6.198305e-4 |
GO:0009410 | response to xenobiotic stimulus | 6.229584e-4 |
GO:0033605 | positive regulation of catecholamine secretion | 6.266643e-4 |
GO:0001936 | regulation of endothelial cell proliferation | 6.412552e-4 |
GO:0031349 | positive regulation of defense response | 6.498818e-4 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 6.571236e-4 |
GO:0008643 | carbohydrate transport | 6.629748e-4 |
GO:0031668 | cellular response to extracellular stimulus | 6.634410e-4 |
GO:0048520 | positive regulation of behavior | 6.667262e-4 |
GO:0070252 | actin-mediated cell contraction | 6.678696e-4 |
GO:0061383 | trabecula morphogenesis | 6.684605e-4 |
GO:0015816 | glycine transport | 6.751734e-4 |
GO:0050793 | regulation of developmental process | 6.758259e-4 |
GO:0048856 | anatomical structure development | 6.779489e-4 |
GO:0015876 | acetyl-CoA transport | 6.851190e-4 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 7.241403e-4 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 7.271537e-4 |
GO:0002026 | regulation of the force of heart contraction | 7.494427e-4 |
GO:0048268 | clathrin coat assembly | 7.508412e-4 |
GO:0060675 | ureteric bud morphogenesis | 7.513715e-4 |
GO:0060676 | ureteric bud formation | 7.628639e-4 |
GO:0007626 | locomotory behavior | 8.276790e-4 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 8.296379e-4 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 8.300273e-4 |
GO:0019222 | regulation of metabolic process | 8.372698e-4 |
GO:0046068 | cGMP metabolic process | 8.439243e-4 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 8.584619e-4 |
GO:0021631 | optic nerve morphogenesis | 8.669783e-4 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 8.794370e-4 |
GO:0045597 | positive regulation of cell differentiation | 8.845427e-4 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 9.262331e-4 |
GO:0048305 | immunoglobulin secretion | 9.296245e-4 |
GO:0002252 | immune effector process | 9.304018e-4 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 9.393798e-4 |
GO:0003056 | regulation of vascular smooth muscle contraction | 9.547248e-4 |
GO:0034341 | response to interferon-gamma | 9.655610e-4 |
GO:0018027 | peptidyl-lysine dimethylation | 9.719702e-4 |
GO:0003350 | pulmonary myocardium development | 9.719702e-4 |
GO:0072522 | purine-containing compound biosynthetic process | 9.832179e-4 |
GO:0002577 | regulation of antigen processing and presentation | 9.889701e-4 |
GO:0006901 | vesicle coating | 9.907438e-4 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 9.918705e-4 |
GO:0010468 | regulation of gene expression | 9.995709e-4 |
GO:0045732 | positive regulation of protein catabolic process | 1.001035e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.004431e-3 |
GO:0048584 | positive regulation of response to stimulus | 1.029555e-3 |
GO:0021559 | trigeminal nerve development | 1.032976e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 1.037397e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.044702e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 1.046254e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.052602e-3 |
GO:0048485 | sympathetic nervous system development | 1.054659e-3 |
GO:0002903 | negative regulation of B cell apoptosis | 1.056269e-3 |
GO:0005976 | polysaccharide metabolic process | 1.058967e-3 |
GO:2000171 | negative regulation of dendrite development | 1.070911e-3 |
GO:0060760 | positive regulation of response to cytokine stimulus | 1.077743e-3 |
GO:0050829 | defense response to Gram-negative bacterium | 1.077743e-3 |
GO:0060341 | regulation of cellular localization | 1.100333e-3 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 1.103217e-3 |
GO:0061044 | negative regulation of vascular wound healing | 1.109807e-3 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 1.109807e-3 |
GO:0071258 | cellular response to gravity | 1.109807e-3 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 1.109807e-3 |
GO:0030704 | vitelline membrane formation | 1.109807e-3 |
GO:0060325 | face morphogenesis | 1.110930e-3 |
GO:0006182 | cGMP biosynthetic process | 1.116370e-3 |
GO:0016055 | Wnt receptor signaling pathway | 1.119026e-3 |
GO:0006548 | histidine catabolic process | 1.133414e-3 |
GO:0030517 | negative regulation of axon extension | 1.134413e-3 |
GO:0032006 | regulation of TOR signaling cascade | 1.136756e-3 |
GO:0021636 | trigeminal nerve morphogenesis | 1.145300e-3 |
GO:0060348 | bone development | 1.160782e-3 |
GO:0006171 | cAMP biosynthetic process | 1.176265e-3 |
GO:0018931 | naphthalene metabolic process | 1.186278e-3 |
GO:0051454 | intracellular pH elevation | 1.199685e-3 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 1.199685e-3 |
GO:0031642 | negative regulation of myelination | 1.199685e-3 |
GO:0006706 | steroid catabolic process | 1.201040e-3 |
GO:0070193 | synaptonemal complex organization | 1.204459e-3 |
GO:0043065 | positive regulation of apoptosis | 1.210975e-3 |
GO:0048747 | muscle fiber development | 1.221500e-3 |
GO:0071295 | cellular response to vitamin | 1.228943e-3 |
GO:0070584 | mitochondrion morphogenesis | 1.241542e-3 |
GO:0010594 | regulation of endothelial cell migration | 1.258839e-3 |
GO:0032101 | regulation of response to external stimulus | 1.260094e-3 |
GO:0010941 | regulation of cell death | 1.269301e-3 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 1.272004e-3 |
GO:0002070 | epithelial cell maturation | 1.274874e-3 |
GO:0046395 | carboxylic acid catabolic process | 1.275259e-3 |
GO:0050906 | detection of stimulus involved in sensory perception | 1.280882e-3 |
GO:0034505 | tooth mineralization | 1.289614e-3 |
GO:0002064 | epithelial cell development | 1.290430e-3 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 1.298367e-3 |
GO:0019319 | hexose biosynthetic process | 1.308483e-3 |
GO:0010543 | regulation of platelet activation | 1.317662e-3 |
GO:0046686 | response to cadmium ion | 1.329589e-3 |
GO:0072358 | cardiovascular system development | 1.336274e-3 |
GO:0048640 | negative regulation of developmental growth | 1.362326e-3 |
GO:0070593 | dendrite self-avoidance | 1.380032e-3 |
GO:0071345 | cellular response to cytokine stimulus | 1.383216e-3 |
GO:0046822 | regulation of nucleocytoplasmic transport | 1.385556e-3 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 1.390576e-3 |
GO:0051954 | positive regulation of amine transport | 1.390576e-3 |
GO:0048013 | ephrin receptor signaling pathway | 1.402081e-3 |
GO:0051252 | regulation of RNA metabolic process | 1.402858e-3 |
GO:0003170 | heart valve development | 1.404683e-3 |
GO:0042330 | taxis | 1.404771e-3 |
GO:0048568 | embryonic organ development | 1.433161e-3 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 1.441421e-3 |
GO:0007275 | multicellular organismal development | 1.449073e-3 |
GO:0001738 | morphogenesis of a polarized epithelium | 1.470789e-3 |
GO:0001711 | endodermal cell fate commitment | 1.482963e-3 |
GO:0006352 | transcription initiation, DNA-dependent | 1.520483e-3 |
GO:0060537 | muscle tissue development | 1.527041e-3 |
GO:0032735 | positive regulation of interleukin-12 production | 1.537028e-3 |
GO:0001568 | blood vessel development | 1.553978e-3 |
GO:0032386 | regulation of intracellular transport | 1.557136e-3 |
GO:0001763 | morphogenesis of a branching structure | 1.580577e-3 |
GO:0009628 | response to abiotic stimulus | 1.586521e-3 |
GO:0050433 | regulation of catecholamine secretion | 1.586852e-3 |
GO:0030514 | negative regulation of BMP signaling pathway | 1.588788e-3 |
GO:0007218 | neuropeptide signaling pathway | 1.595517e-3 |
GO:0002066 | columnar/cuboidal epithelial cell development | 1.596920e-3 |
GO:0002830 | positive regulation of type 2 immune response | 1.606929e-3 |
GO:0050885 | neuromuscular process controlling balance | 1.620068e-3 |
GO:0043068 | positive regulation of programmed cell death | 1.628589e-3 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 1.643613e-3 |
GO:0060538 | skeletal muscle organ development | 1.643871e-3 |
GO:0006935 | chemotaxis | 1.647972e-3 |
GO:0010721 | negative regulation of cell development | 1.649154e-3 |
GO:0006979 | response to oxidative stress | 1.653854e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 1.656182e-3 |
GO:0051291 | protein heterooligomerization | 1.659478e-3 |
GO:0006164 | purine nucleotide biosynthetic process | 1.673385e-3 |
GO:0045792 | negative regulation of cell size | 1.685747e-3 |
GO:2000106 | regulation of leukocyte apoptosis | 1.702096e-3 |
GO:0008361 | regulation of cell size | 1.713917e-3 |
GO:0001764 | neuron migration | 1.724757e-3 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 1.754111e-3 |
GO:0046110 | xanthine metabolic process | 1.754111e-3 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 1.754111e-3 |
GO:0008037 | cell recognition | 1.768887e-3 |
GO:0030203 | glycosaminoglycan metabolic process | 1.769256e-3 |
GO:0021955 | central nervous system neuron axonogenesis | 1.769695e-3 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 1.773123e-3 |
GO:0032236 | positive regulation of calcium ion transport via store-operated calcium channel activity | 1.779050e-3 |
GO:0032964 | collagen biosynthetic process | 1.780593e-3 |
GO:0046034 | ATP metabolic process | 1.790514e-3 |
GO:0000165 | MAPKKK cascade | 1.796139e-3 |
GO:0030183 | B cell differentiation | 1.820629e-3 |
GO:0006534 | cysteine metabolic process | 1.858124e-3 |
GO:0048708 | astrocyte differentiation | 1.862840e-3 |
GO:2000026 | regulation of multicellular organismal development | 1.881612e-3 |
GO:0032757 | positive regulation of interleukin-8 production | 1.904950e-3 |
GO:0042178 | xenobiotic catabolic process | 1.919203e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 1.923296e-3 |
GO:0060299 | negative regulation of sarcomere organization | 1.923296e-3 |
GO:0015761 | mannose transport | 1.923296e-3 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 1.923296e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 1.923296e-3 |
GO:0002685 | regulation of leukocyte migration | 1.928803e-3 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 1.929289e-3 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 1.933803e-3 |
GO:0051453 | regulation of intracellular pH | 1.951775e-3 |
GO:0019254 | carnitine metabolic process, CoA-linked | 1.953067e-3 |
GO:0014054 | positive regulation of gamma-aminobutyric acid secretion | 1.964955e-3 |
GO:0006072 | glycerol-3-phosphate metabolic process | 1.964955e-3 |
GO:0003007 | heart morphogenesis | 1.984184e-3 |
GO:0048523 | negative regulation of cellular process | 1.991734e-3 |
GO:0030534 | adult behavior | 1.992529e-3 |
GO:0032760 | positive regulation of tumor necrosis factor production | 2.018189e-3 |
GO:0031346 | positive regulation of cell projection organization | 2.026631e-3 |
GO:0003179 | heart valve morphogenesis | 2.043573e-3 |
GO:0048705 | skeletal system morphogenesis | 2.045500e-3 |
GO:0002572 | pro-T cell differentiation | 2.058611e-3 |
GO:0070474 | positive regulation of uterine smooth muscle contraction | 2.058611e-3 |
GO:0044270 | cellular nitrogen compound catabolic process | 2.080024e-3 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.085456e-3 |
GO:0051924 | regulation of calcium ion transport | 2.087340e-3 |
GO:0009214 | cyclic nucleotide catabolic process | 2.092747e-3 |
GO:0031670 | cellular response to nutrient | 2.111167e-3 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 2.139145e-3 |
GO:0051251 | positive regulation of lymphocyte activation | 2.143434e-3 |
GO:0032206 | positive regulation of telomere maintenance | 2.162103e-3 |
GO:0001692 | histamine metabolic process | 2.162103e-3 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 2.192585e-3 |
GO:0050432 | catecholamine secretion | 2.212634e-3 |